Keren Haruvi, US President and Head of North America, Sandoz US, discusses the near and longer term opportunities for generics and biosimilars as well as her insights in starting in this new role at the height of the pandemic.

In her role as Global Senior VP, Chief Marketing Officer at LifeScan, Lisa Rose is shaping how people speak about diabetes care as she advocates for a more holistic approach to wellness.

Dr. Elizabeth Hewitt provides an insider’s perspective as an orthopedic surgeon, innovator, how she is changing care in her community in light of the COVID pandemic.

Stephanie Brown — a scientist at heart and a skilled marketer — is combining her two worlds to bring rare disease treatments to forefront in her senior leadership commercial, communications and external affairs role at Ipsen.

Wendy Lund, Chief Communications Officer, discusses Organon’s transformation into a women’s health company whose mission is to create a better and healthier every day for every woman — knowing that women are foundational to a healthier world.

Jacylyn Dougherty, Chief Information and Technology Officer at Elligo, recalls her journey to the C-suite as one of the few women to attain this title in the life-sciences industry as well as the important trends she is tracking that will impact clinical trials now and in th … Read More »

Ryan Pack, Global Head Diversity in Clinical Trials at Science 37, brings passion, energy, talent, and a generational legacy to her role and ambition to change the trajectory of diversity and equity in clinical trials by ensuring everyone’s voice is heard and included.

Dr. Laura Niklason, Founder, President, and CEO of Humacyte is transforming the field of regnerative medicine from science fiction into science fact in her pursuit of bringing bioengineered human acellular vessels to market and along the way taking the company public.

Jen Goldsmith, President of Tendo Systems, is envisioning a healthcare system built for tomorrow based on a next-generation digital engagement platform and applications that seamlessly connect patients, clinicians, and caregivers throughout the care cycle.

Laura Randa, Chief Commercial Officer of Curio Digital Therapeutics, details her incredible journey of career rediscovery and how her passion to help others has become a vital part of her personal brand.

Dr. Diana Brainard of AlloVir, discusses her transition into the role of a first-time CEO, the opportunities around developing allogeneic, off-the-shelf virus-specific T Cell (VST) therapy candidates, and how she kept her team motivated during COVID.

Kim Mehle, VP, Oncology Commercial Services, IQVIA, shares her perspectives on the importance of analytic solutions that examine patient and physician behavior in the oncology field and what this means for clinical research in the future as well her tips for developing high- … Read More »

A translational neuroscientist, Dr. Retsina Meyer, Head of Strategic Projects and Alliances at Delix Therapeutics, brings the field of neuroscience to life by sharing her passion and vision of what the future holds in terms of personalized medicine for neurological disorders … Read More »

A passionate advocate for women progressing in STEM careers, Nancy Lurker, CEO and President of EyePoint Pharmaceuticals, journals her extraordinary career providing great insights on making it to the C-Suite, including identifying intentional goals, taking prudent risks, an … Read More »

Christi Shaw, CEO of Kite, a Gilead Company, shares her personal story of loss and how this journey ignited a passion to change the future of oncology drug development and the difference that the company’s CAR T transformative medicines can mean to patients in need.

Jennifer Aquino, VP, Digital Patient Suite at IQVIA, talks about her passion for drug development, how she inspires her teams to achieve big audacious goals, and the need for continued collaboration and interoperability of systems as the industry looks toward a post-COVID wo … Read More »

Jill Quigley, COO of Passage Bio, who was employee No. 1, discusses the company’s evolution as a genetic medicines company developing transformative therapies for the treatment of rare monogenic central nervous system disorders, and leadership lessons learned along the way.

Erica Cohen, Senior VP, Operations at Greenphire, who has been dedicated to creating a work environment that is both balanced and empowering for years, shares insights on generating process efficiency and operational excellence.

With more than three decades of experience leading global teams, including time well spent at Intel and Google Cloud driving strategy and insights, Diane Bryant has been identified as one of the most powerful women in technology. Now heading up NovoSignal, an innovative med- … Read More »

Sharon Cunningham, CEO and Co-founder of Shorla Pharma, shares her tips on launching a successful entrepreneurial venture as well as her vision for the future of oncology drug development focused on women’s and pediatric health.

Katrina Rice, Chief Delivery Officer, Data Services, shares her authentic journey to the C-suite, how she found her voice and seat at the table, why she is a passionate advocate for paying it forward for women, and poignant lessons in leadership.

Nancy Di Dia, the OG of DE&I, shares her passion for creating an equitable workplace in the pursuit of better health outcomes for patients as well as her personal story that influenced her very successful and purposeful career.

As philanthropist, President, Co-Founder, and Member of the Board of Directors of The Termeer Foundation, Belinda Termeer shares her vision for elevating Henri Termeer’s life’s work and legacy as one of the founders of the biotechnology industry.

As VP, Head of Medical Writing at Bioforum, Dr. Shiri Diskin shines a light on the important role she plays in the drug development process and the instrumental guidance she provides clients and researchers to clarify their scientific rational and findings.

Melissa “Lis” Easy, VP, R&DS Technologies, IQVIA, discusses her passion and mission to help sponsors and CROs connect with investigators and sites more efficiently, as well as her thoughts on what the future holds in terms of DCTs, and provides some valuable career advic … Read More »

Julie Foster, VP, Customer Experience Medtronic Diabetes, is passionate about her pursuit to improve the patient journey, drive business innovation, and create end-to-end tech-enabled solutions that improve the 180 decisions diabetic patients need to make each and every day.

Having launched more than 90 products and services across a wide variety of organizations, Allison London Brown brings a wealth of experience to her role as CEO of UVision360 where is committed to transforming women’s health.

Jeannette Bankes, President & General Manager, Global Surgical Franchise, shares meaningful career insights along her progression to the C-suite as well as major trends and advances within the global ophthalmology area.

Dr. Susan Galbraith, Senior VP of Early Oncology, AstraZeneca, discusses her personal career journey with oncology and drug development as she works to improve patients’ lives as well as her passion for paying it forward.

Dr. Joanne Quan, Chief Medical Officer, Modis Therapeutics, is a scientific problem-solver, collaborator, and ideator whose future-thinking approach to innovation is integral to crystalizing abstract concepts into concrete solutions to help patients.

Throughout her career as an entrepreneur and C-suite executive Michelle Hefley has been blazing a path in the orphan and rare disease space. Now as Co-Founder, Managing Partner, and Chairman of Optime Care, she is continuing to bridge the gap and provide meaningful services … Read More »

Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain to democratize treatments focused on personalized medicines. This is not her first moon shot to give power to patients.

President of Cardinal Health Specialty Heidi Hunter, an accomplished global healthcare leader with deep experience in innovation, development, and commercialization of specialty pharmaceuticals, discusses the latest trends in the space as well as lessons learned in building … Read More »

Rebecca Vermeulen, VP Patient & Society Strategy Product Development, Head of Healthcare and Patient Partnership Teams, at Roche/Genentech is passionate about creating opportunities for patients to own their health; she is also a role model to so many, having served as b … Read More »

Recently named as Parexel’s first Chief Patient Officer, Dr. Clare Grace is blazing a new path as she looks to innovate and clearly define the future role of patients in the drug development process.

Nina Wachsman, CEO of Know Rare, talks about her extraordinary journey into the rare disease space and what drives her passion to make a difference for this unique patient community — plus she provides a glimpse into her life as a mystery writer.

Dr. Andrea Itano, Senior VP, Head of Research at Evelo Biosciences, who is leading a dedicated team of scientists shares her insights on how the company is unlocking the therapeutic possibilities of novel microbial science, as well as the benefits of mentoring and the import … Read More »

Laura Blair, Senior VP, Business Development, ConnectiveRx, details her powerful real-life journey as a cancer survivor and how her experience as a patient and brand advocate helped her to navigate the complex healthcare system.

2020 PharmaVOICE 100 honoree Dr. Gail McIntyre talks about her passion and journey to cure cancer, which started in grade school culminating in her being named CEO of Aravive and her vision for the future of oncology.

Dr. Kate Broderick, Senior VP, Research and Development, Inovio, details how she and her team designed a DNA-based COVID-19 vaccine model in three hours as well as her passion for research and developing women scientists.

Anne Quinn Young, Chief Marketing and Development Officer, MMRF, discusses the groundbreaking and inspirational work the organization is undertaking to benefit patients as well as why she thinks a “cure” for multiple myeloma is no longer out of reach.

In addition to her role as Director of Business Development at Selexis, Jessica Bosc is President of Women In Bio, where she led the nonprofit organization’s successful pivot during the year to reach its goals and continue its mission on behalf of women in the biotech sector … Read More »

Valerie Palmieri, President and CEO of Aspira Women’s Health, who is moving mountains to address the serious health needs of women, shares her leadership vision and passion for science.

Lourdes Felix, CEO, Chief Financial Officer, and Director of BioCorRx, has the passion and desire to help as many individuals as possible who suffer from substance abuse disorders and she is committed to removing the barriers that prevent them from receiving the care they ne … Read More »

Natalie Douglas, Cofounder of RareiTi, discusses the evolving and important role that managed access plays to address serious patient needs as well as her journey as an entrepreneur and worldclass change agent.

April Lewis, Executive VP of Hū, a W2O company, talks about the launch of the new patient activation organization and the importance of engaging patients to participate in clinical trials.

Elaine O’Hara, Chief Commercial Officer, Head of North America Commercial Operations, Sanofi Pasteur, the vaccines division of Sanofi, provides her insights on the role vaccines play in public health and what companies can do to educate the public to dispel the misperception … Read More »

Tanya du Plessis, VP of Data Strategies and Solutions at Bioforum, discusses the important trends impacting data management and clinical trials as well as managing a global team during a global pandemic.

Donna LaVoie, President and CEO of LaVoie Health Systems, describes her entrepreneurial journey, the potential of the biotech industry, and the importance of PR.

Dr. Jill O’Donnell-Tormey, who has been CEO of the Cancer Research Institute for nearly 35 years, discusses why she believes supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers is the future.

Dr. Helen Hyun Jung Lee, President and CEO of Samyang Pharmaceuticals, has taken several bold steps in her career leading to her current position where she is spearheading innovative approaches in oncology drug development.

Saundra Pellietier, CEO of Evofem, shares her inspirational story of success as she looks to leave her footprint on this planet by transforming the field of women’s healthcare around the world by empowering change.

Amanda Powers-Han, Senior Partner, Media, at Greater Than One, discusses how she unleashes the imagination of her team to capitalize on the biggest opportunities in healthcare communications today.

Jody Casey, VP of Healthcare Partnerships, at Elligo Health Research, identifies trends in the clinical trial arena and ways in which clinical research can become part of a care option.

Georgette Pascale, Founder and CEO of Pascale Communications, discusses her entrepreneurial journey, trends impacting PR/communications, and why the industry’s reputation is more important than ever.

Shonda Anderson-Williams, Healthcare & Life Sciences Digital Transformation Leader at Microsoft, discusses the impact that digital is having on the life-sciences industry and how she is paving the technology path for other women.

Beenu Kapoor, VP, IT Trial Management, Products Lead, IQVIA, is seizing the opportunity to move out of her comfort zone to transform clinical trials through digital technology to benefit all stakeholders.

Tzvia Bader, CEO, of TrialJectory is tapping into her very personal experience as a cancer survivor and three-time clinical trial participant to benefit other patients who are searching for clinical trial information by taking some bold entrepreneurial leaps to create a new … Read More »

Eloiza Domingo, Executive Director and Global Head of Engagement, Diversity & Inclusion, at Astellas is blazing a trail to bring cultural competency to the forefront thereby fulfilling multiple goals: improving patient outcomes, addressing systemic areas of gender and ra … Read More »

Maria Tender, Head of Strategy – Communications at Syneos Health, who brings more than two decades of consumer experience to her new role, describes how she unleashes talent to make health communications stand out.

Dr. Linda Marbán, President, CEO, and Co-Founder of Capricor, talks about her passion for the field of biotech as well the company’s exciting first-in-class cell and exosome-based therapeutics.

Teri Loxam, CFO of SQZ Biotech, has taken bold moves throughout her career to master two critical skills — finance and communications — both of which give her the unique ability to create a powerful story about the company’s groundbreaking cell therapy science.

For Barbara Enger, associate VP, clinical science at Signant Health, patients are everything; she is driving initiatives to make sure patient voices are included along with those of clinicians and sites in terms of product development.

Kate Cronin, president of Ogilvy Health, identifies several trends to watch for in healthcare advertising, her approach to mentoring, and why it’s important for the industry to strive for greater diversity and inclusion.

Dawn Fallon, practice lead, health, at Makovsky, enumerates the challenges and opportunities within PR and communications given the current environment with so many different channels available as well as the keys to successful campaigns.

As chief scientific officer of BridgeBio, patients are at the heart of everything Dr. Uma Sinha does as she looks to take multiple shots on goal with a focused approach to drug development in the rare disease space.

Kimberly Stephens, who brings extensive financial acumen as well as a proficiency in raising equity to her role as CFO at the biotech start-up Appilli Therapeutics, shares some of her professional insights on getting comfortable with being uncomfortable in her ascension to t … Read More »

Elizabeth Jeffords is using her vast experience in global roles to lead the commercial and strategic direction of a biotech company focused on diseases of the aging while fostering the next generation of women-owned businesses through her volunteer efforts.

As VP, External Innovation anv New Ventures at a life-sciences accelerator, Dr. Shobha Parthasarathi is applying her wealth of scientific knowledge and keen business instincts and acumen to identify and advance technologies/companies from early development through clinical p … Read More »

As a world-class athlete, Dr. Carol Addy is harnessing her competitive spirit in leading her clinical team’s pursuit of bringing first-in-class treatments to market.

Dr. Rebecca Kusko, Chief Strategy Officer at Immuneering Corp., has carved out a purposeful, yet unorthodox, path to the C-suite as well as serving as a mentor to women. Trained as a computational biologist, she is using her love for creative problem solving to benefit patie … Read More »

As chief scientific officer of Soligenix, Oreola Donini, Ph.D., is directing the company’s R&D strategy to addresses unmet medical needs in the areas of inflammation, oncology, as well as biodefense. She shares her inspirational and scientific journey in reaching the C-s … Read More »

Michelle Longmire, M.D.’s inspirational and entrepreneurial journey is focused on transforming the clinical trial landscape. She brings a highly competitive spirit to her role as a leader and industry disrupter.

Dr. Holly Kordasiewicz has spent her whole career in the pursuit of understanding neurodegenerative diseases; she is passionate about the progress she and her team at Ionis are making in their research using antisense oligonucleotide therapeutics to treat ALS, Alzheimer’s di … Read More »

Susanne Munksted, as one of the first, if not the first, executives to be named as a Chief Precision Officer of a diagnostic or pharma company, brings a wealth of experience to her role in leading a global commercial team to improve the testing ecosystem to help patients cap … Read More »

Mary Szela, who has a reputation for building billion-dollar businesses, turning around faltering businesses, igniting growth in stagnant businesses, and devising innovative, differentiated strategies for undistinguished products, shares the many lessons she has learned alon … Read More »

Cinda Orr discusses her entrepreneurial journey in building a leading marketing firm in the life sciences with a people-first focus as well as her perspective on trends in the clinical arena.

Dr. Margaret Yu, a passionate champion of women in the field of STEM, discusses her path from physician to oncology researcher with a specific focus on prostate cancer and her vision for the future of treatment.

Dr. Jessica Grossman, who is CEO of Medicines360 one of the very few nonprofit pharma companies, is passionately committed to furthering women’s health equity. At the same time, she fully believes in creating opportunities that allow women to let themselves shine.

Sharon Callahan — Chairman of TBWA\WorldHealth Group, Chief Client Officer of Omnicom Health Group, and the newly named CEO of The CDM Group — shares her inspirational journey as the 2019 HBA Woman of the Year, discusses her vision for the future amid COVID-19, and shares he … Read More »

After two decades working in the CRO industry, Kellie Malloy Foerter is applying her considerable knowledge and expertise to guide OncoSec Medical’s clinical development programs for cancers with limited treatment options. At the same time, she is tracking exciting new ways … Read More »

Dr. Sharon Shacham is one of the few drug developers who has brought a drug — Xpovio — from inception to an FDA approval. She talks about her incredible journey, which led to receiving the 2019 “Inventor of the Year” Award from The New York Intellectual Property Law Associat … Read More »

Smital Shah shares the lessons she learned as a financial strategist and investment banker, which she is now using to help guide ProQR, a rare disease company, to bring much-needed treatments to patients.

Susan Kalk’s passion for chemistry extends down to the atomic level, which has been one of the drivers for ensuring the safety and quality of medicines for the marketplace. As one of the few women in a large pharma company to lead the quality function, she has created a path … Read More »

Sandy Solmon wears several hats, she leads a private, emerging medical technology company that develops stem cell-based regenerative therapies for the treatment of CNS disorders and she is CEO, chief innovator, and founder of Sweet Street Desserts, the world’s largest manufa … Read More »

Investment banker, deal maker, and passionate supporter of innovation and entrepreneurship, Renee Ryan brings a unique skill set to her role as CEO as she looks to transform the standard of care for chronic disease through bioelectronic medicine.

As a board-certified genetic counselor, Karmen Trzupek is passionate about addressing speciality care and increasing clinical trial enrollment via a telemedicine model and she is purpose-driven to increasing access to care through the role genetic testing plays now and in th … Read More »

Believing in the power of one, Kinnari Patel’s passion around rare disease is leading to unique development programs and awareness campaigns; she is equally passionate about sharing her learnings on the way to the C-suite as a mentor and sponsor.

An expert in bioethics as well as a physician, Dr. Lindsay McNair brings deep expertise and empathy to her role as chief medical officer as she looks to transform the clinical trial paradigm.

Rauha Tulkki-Wilke leads a global virtual clinical team in pursuit of creating eCOA solutions that provide measurable benefits for sites and patients.

Dr. Susan Dorfman, who is a force of nature, believes communication is the stalwart of medical care and exhibits an anything-is-possible commitment to understanding physician and consumer marketing behaviors.

A role model in the field of technology, Kaisa Helminen discusses how AI is changing clinical development, believing it will be part of the standard of care in 10 years.

Mary Anne Greenberg, a C-suite veteran, discusses her people-first approach to leadership, lessons learned along the way, and how she translated skills learned in the movie business to benefit patients and caregivers.

Catherine Ivy, who lost her husband a decade ago to a devastating and sudden brain cancer, shares her personal journey of grief and purpose, which led to the founding of the Ivy Brain Tumor Center at the Barrow Neurological Institute.

Dr. Anne Heatherington discusses Takeda’s Data Sciences Institute and the important role this group plays in the company’s overall R&D strategy as well as the biggest trends in data and analytics she and her group are tracking.

Kathy Vandebelt provides an inspired look inside clinical innovation based on a 30-year global career during which she has positively impacted thousands of patients as well as colleagues.

Corlis Murray, a leader and advocate for STEM, was instrumental in orchestrating Abbott’s blueprint for engaging girls and women in science, technology, engineering, and math. As one of the senior-most African American women leaders in the industry, she is a stalwart champio … Read More »

Patricia Malone is leading the charge in the West with her second start-up agency and providing inspiration to a new generation of creative talent.

Dr. Athena Countouriotis’ inspiring career journey, including one of the best biotech IPOs this year, now has her in pursuit of developing targeted cancer therapies designed to address treatment resistance and improve lives.

Laura Shafner shares her personal story around the role medicine and behavior play and talks tech about how artificial intelligence can uncover new ways of addressing drug development.

Casey Lynch, a serial entrepreneur, is changing the perception of what being a biotech CEO means today as her company, which recently went public, explores new avenues to address Alzheimer’s disease.

Kimberly Haugstad, the new CEO of Global Genes, outlines what the future holds for the 10-year old organization as it continues to address the needs — support and research — for patients and families in the rare disease community.

Dr. Ahnal Purohit is an entrepreneur, innovator, and visionary. She has been upending the status quo since launching her own company as she reshapes pharmaceutical advertising.

Born to be a leader, Dr. Sophia Ononye’s intense curiosity, passion, energy, as well as her immigrant experience, give her a unique perspective as she strives to transform peoples’ lives around the world.

Dr. Gwen Nichols shares her inspirational career journey from bench scientist to pharma to chief medical officer and her vision for changing the paradigm around pediatric clinical trials and lessening the burden on patients.

Jessica Scott, M.D., provides an inspiring and insightful account of her innovative approaches to elevate patient engagement during R&D to a new level as well as how the intersection of her medical and law degrees have influenced her career and passion for patients.

Peyton Howell, a pioneer in patient access and reimbursement, shares her vision to synchronize commercialization and R&D strategies as well as her inspiring leadership principles around performance capital and managerial courage.

Dr. Meredith Terry, a behavioral science expert, explores the role social psychology plays in communicating with patients, the keys to developing successful programs, and her passion on making a difference in the healthcare arena.

Barbara Lopez Kunz outlines her near-and long-term vision to achieve the DIA’s global objectives, the importance of the volunteer corps who keeps the organization fresh, and why she believes in paying it forward.

Carolyn Morgan discusses her journey to the top and what it’s like to lead one the top healthcare agencies and how she balances career and life.

Dr. Anna Sundgren shares her passion to drive innovation around chronic kidney disease as well as how her global perspective influences her leadership and strategic vision.

Jennifer Gottlieb, a powerhouse leader running a global, top 10 healthcare agency, talks about some of the biggest trends, talent management, women’s leadership, and balancing a high-powered career and high-energy life.

Dr. Lan Huang, a serial entrepreneur, with a dual cultural approach, is devoted to driving innovative immuno-oncology cancer therapies to market. Her inspiring leadership approach and passion are rooted in her past and in the future.

Liz Pinto has built a successful career on developing high-touch, sophisticated patient-led initiatives that create positive experiences for both patients and caregivers.

Dr. Terri Phillips is a physician, retired US Army Major, global medical affairs expert, and Women’s Leadership Network leader, whose career is defined by her personal mantra: if you believe it, then you can achieve it.

Kim Johnson discusses some the key trends that will impact healthcare advertising, the role of transformative technology, and the core values that drive her and her teams to do good work.

Janet Kosloff talks about her entrepreneurial journey, market research trends, and interesting data from a longitudinal study involving female physicians.

Dr. Jones-Burton, a leading expert in cardiology, is on a mission to remove the systemic barriers that impact the lack of diversity from drug discovery through commercialization.

Dr. Paula Ragan founded X4 Pharmaceuticals with the goal to advance innovative medicines to treat rare diseases and along the way is paving a path for gender diversity in biotech.

Anjum Swaroop describes how her relentless persistence led to an industry-changing career at Dr. Reddy’s.

Shontelle Dodson’s focus is on patients — improving patient access to medications as well as bringing value to patients. She also leads Astellas’ Oncology C3 Prize, which aims to to change cancer care beyond medicine in terms of the cancer care journey, cancer health dispari … Read More »

Dr. Andrea Pfeifer is taking Alzheimer’s research to the next level through collaboration and treating the pathology of disease, which in turn has the potential change the future of drug development.

Dr. Mannick describes the incredible work her company is doing in the field of aging and shares some of her key leadership insights, hint: On to Cincinnati.

Laurie Bartolomeo, a creative strategist, discusses her passion around rare disease and why she is invested in making a difference for patients and caregivers.

Jessica Rousset, a technologist, is not just a role model for other women in the industry, she is driving healthcare innovation to bring new medicines to patients.

Dr. Ubavka DeNoble in her new role as chief commercial officer discusses the wide ranging impact that technology will play in clinical research, clinical trials, and post-marketing patient engagement.

Laurie Cooke celebrates the 30th anniversary of the Woman of the Year event with some key takeaways, discusses the important strides the HBA is taking to address the issue of gender parity, and provides words of inspiration for women at all levels in their careers.

Jayne Gershkowitz is a passionate advocate and expert in a wide variety of issues affecting individuals with rare diseases and their families. She has more than 18 years of experience of strategic marketing, resource development and executive management in nonprofit healthca … Read More »

Kathy Giusti, who is revolutionizing the area of precision medicine as faculty co-chair of HBS Kraft Precision Medicine Accelerator at Harvard Business School, describes her professional and personal mission to transform how medicines are discovered and developed.

Sheri Madrid talks about how her love of science has led to a multi-tiered and successful career as a clinical operations executive as well as how a company culture of transparency and honesty can yield remarkable results.

Throughout Dr. Gisela Schwab’s extensvie career she has stretched herself and expanded her knowledge base all leading to a place where she is making a considerable difference in the lives of cancer patients.

Liz Lewis discusses how she balances dual responsibilities as well as the importance of the journey and taking advantage of opportunities that may arise along the way to create an enriching and fulfilling career.

Dr. Deborah Dunsire’s journey of an intellectually and emotionally captivating career has guided her to pursue transformative medicines with high unmet medical needs on her way to the C-suite.

Clareece West discusses how science and technology are merging to improve and advance devices and therapies for all patients.

Dr. Shannon Dahl, a pioneer in regenerative technology, is driving innovation to new levels to bring off-the-shelf cell therapies to patients.

Gail Moore’s personal story fuels her passion for greater collaboration, innovation, and advocacy in the rare disease space.

Melinda Richter is changing the way the industry thinks about innovation, based on her vision of what success looks like: doing important work that makes an impact, and doing that with people you care about.

Colleen Carter shares her three guiding principles to having a more purposeful life — personally and professionally.

Through the power of science and technology, Dr. Helen Torley is committed to transforming patient care.

Dr. Georgia Mitsi is passionate about the impact that digital and mobile can have on patients, especially those living with chronic medical conditions.

Amy Heymans is creating a new type of Health Experience through a futuristic and innovative approach encompassing organizational design and behavior change.

Lynn O’Connor has a passion for disruption and she is using her futurisitic vision to lead the Muscular Dystrophy Association to new heights while respecting the legacy of the nonprofit’s origins.

Jennifer De Camara’s love of law and science is the perfect combination when it comes to patient advocacy and being a healthcare champion.

Rachel King has charted a unique career — from consultant to VC to startup to now CEO — and is leading a pioneer company in the use of glycobiology technology.

Wendy White is a passionate and innovative leader working at the intersection of advocacy, technology, and business in the rare disease space.

Dr. Fardis recounts how her love of science has been a guiding light throughout her career as she has moved from the lab to the C-suite.